FindTrial
Sign In

Effects of transcutaneous acupoint electrical stimulation on breast cancer patients with sleep disturbance during and after operation

Effects of transcutaneous acupoint electrical stimulation on breast cancer patients with sleep disturbance during and after operation: a single-center, study designer blind, prospective, nonrandomized controlled, superior clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006539
Enrollment
Unknown
Registered
2022-08-25
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep disturbance

Interventions

Blank control group:blank control
sleep disorder control group:sleep disorder control
sleep disorder with transcutaneous acupoint electrical stimulation group :transcutaneous acupoint electrical stimulation

Sponsors

Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Breast cancer surgery patients; ? ASA grade I~ ?; ? Age 18-70; ? normal and no communication disorders; ? The operation time is greater than or equal to 30 minutes.

Exclusion criteria

Exclusion criteria: ? Patients who refused to participate in the study; ? Patients with severe intraoperative or postoperative complications or patients who need to be transferred to ICU for treatment; ?patients with pacemakers; ? Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; ? A history of severe neurological and mental illness; ? The selected acupoint stimulation location has infection or injury.

Design outcomes

Primary

MeasureTime frame
VAS pain grade;Postoperative sleep score;—

Secondary

MeasureTime frame
Postoperative hospital stay;Intraoperative heart rate variability;T cell subsets;Postoperative analgesic drug dosage;inflammatory factor;Intraoperative hemodynamic index;C-reactive protein;postoperative nausea and vomiting;Postoperative blood cell analysis;Intraoperative dose of vasoactive drugs;BIS recovery time after drug withdrawal;—

Countries

China

Contacts

Public Contactliwenzhi
wenzhili9@126.com18045159998

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026